Fenofibrate plus rosiglitazone lowers HDL-cholesterol levels

被引:0
|
作者
机构
关键词
Cholesterol; Diabetes Mellitus; Type Diabetes Mellitus; Type Diabetes; Cholesterol Level;
D O I
10.2165/00128415-200410190-00008
中图分类号
学科分类号
摘要
引用
收藏
页码:4 / 4
相关论文
共 50 条
  • [1] Therapies to Increase ApoA-I and HDL-Cholesterol Levels
    Brown, William M.
    Chiacchia, Fabrizio S.
    DRUG TARGET INSIGHTS, 2008, 3 : 45 - 54
  • [3] HDL-Cholesterol: Perfection is the Enemy of Good?
    Baliga, Ragavendra R.
    MEDICAL CLINICS OF NORTH AMERICA, 2012, 96 (01) : 27 - +
  • [5] Determinants of an Optimal Response to Pioglitazone in Terms of HDL-Cholesterol
    Kabeya, Yusuke
    Tomita, Masuomi
    Asai, Yoichiro
    Katsuki, Takeshi
    Oikawa, Yoichi
    Meguro, Shu
    Shimada, Akira
    Atsumi, Yoshihito
    INTERNAL MEDICINE, 2011, 50 (08) : 825 - 831
  • [6] HDL-cholesterol and cardiovascular disease: rethinking our approach
    Siddiqi, Hasan K.
    Kiss, Daniel
    Rader, Daniel
    CURRENT OPINION IN CARDIOLOGY, 2015, 30 (05) : 536 - 542
  • [7] Niaspan®:: creating a new concept for raising HDL-cholesterol
    McGovern, M
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2005, 7 (0F) : F41 - F47
  • [8] HIGH PLASMA VITAMIN-C ASSOCIATED WITH HIGH PLASMA HDL-CHOLESTEROL AND HDL(2)-CHOLESTEROL
    HALLFRISCH, J
    SINGH, VN
    MULLER, DC
    BALDWIN, H
    BANNON, ME
    ANDRES, R
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1994, 60 (01): : 100 - 105
  • [9] Molecular Mechanisms of HDL-Cholesterol Elevation by Statins and Its Effects on HDL Functions
    Yamashita, Shizuya
    Tsubakio-Yamamoto, Kazumi
    Ohama, Tohru
    Nakagawa-Toyama, Yumiko
    Nishida, Makoto
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2010, 17 (05) : 436 - 451
  • [10] HDL-cholesterol: Is it really good? Differences between apoA-I and HDL
    Santos-Gallego, Carlos G.
    Ibanez, Borja
    Badimon, Juan J.
    BIOCHEMICAL PHARMACOLOGY, 2008, 76 (04) : 443 - 452